Article Per Year (5 Year)
p-Index From 2021 - 2026
4.939
P-Index
This Author published in this journals
All Journal Farmasains : Jurnal Farmasi dan Ilmu Kesehatan Natural Science: Journal of Science and Technology LINK Indonesian Journal of Pharmaceutical Science and Technology Biocelebes The Indonesian Journal of Public Health Pharmascience Berkala Kedokteran JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) As-syifaa Jurnal Farmasi Acta Pharmaciae Indonesia : Acta Pharm Indo Majalah Farmaseutik Jurnal Farmasi Indonesia Jurnal Farmasi Higea Jurnal Kefarmasian AKFARINDO PREPOTIF : Jurnal Kesehatan Masyarakat Jurnal Insan Farmasi Indonesia Journal of Health Community Service Media Publikasi Promosi Kesehatan Indonesia (MPPKI) Jurnal Pengabdian Kesehatan Masyarakat Healthy Tadulako Journal (Jurnal Kesehatan Tadulako) Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Journal of Health and Nutrition Research Jurnal Pengabdian Farmasi dan Sains Jurnal Farmasi Galenika
Muhamad Rinaldhi Tandah
Department Of Pharmacy, Faculty Of Mathematics And Natural Sciences, Tadulako University, Indonesia
Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Computer Science & IT Dentistry Education Environmental Science Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Physics Public Health Social Sciences Veterinary Other

Published : 42 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 42 Documents
Search

 1   2   3   4   5 
Analisis Efektivitas Biaya Penggunaan Antibiotik Levofloksasin dan Azitromisin pada Pasien Penderita Corona Virus Disease-19 pada Tahun 2021 di RSUD Madani Palu: Cost-Effectiveness Analysis of Levofloxacin and Azithromycin Antibiotics Usage in Patients with Corona Virus Disease-19 in 2021 at Madani Hospital in Palu Tandah, Muhamad Rinaldhi; Ririen Hardani; Nurhafifah Wulandari Kassa; Nurul Ambianti
Media Publikasi Promosi Kesehatan Indonesia (MPPKI) Vol. 6 No. 7 (2023): July 2023
Publisher : Fakultas Kesehatan Masyarakat, Universitas Muhammadiyah Palu

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56338/mppki.v6i7.3262

Abstract

Latar belakang: Corona Virus Disease 2019 (Covid-19) merupakan penyakit menular yang disebabkan oleh Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 yang dapat menyebabkan gejala gangguan pernapasan akut seperti demam, batuk dan sesak napas. Dalam penatalaksanaannya, Covid-19 membutuhkan biaya yang besar. Tujuan: Penelitian ini bertujuan untuk mengetahui antibiotik manakah yang paling cost-effective antara azitromisin dan levofloksasin dalam pengobatan Corona Virus Disease-2019 periode 2021 di RSUD Madani Palu. Metode: Desain penelitian ini adalah observasional cross-sectional dengan pengambilan data pasien secara retrospektif (Januari-Desember 2021). Metode penelitian pada penelitian ini adalah purposive sampling. Analisis efektivitas biaya dilakukan dengan menghitung Average Cost Effectiveness Ratio (ACER) dan Incremental Cost Effectiveness Ratio (ICER). Hasil: Jenis kelamin laki-laki sebesar 51% dengan usia 26-45 tahun dibandingkan perempuan sebesar 49%, dan lama rawat inap terbanyak 14 hari. Biaya medis langsung pasien pengguna azitromisin lebih rendah sebesar Rp1.659.698,66 dibandingkan pasien pengguna levofloksasin sebesar Rp1.711.361,17. Nilai ACER antibiotik azitromisin sebesar Rp92.205 dan nilai ACER antibiotik levofloksasin sebesar Rp136.939. Kesimpulan: Dapat disimpulkan bahwa kelompok terapi antibiotik azitromisin lebih cost-effective dibandingkan dengan kelompok terapi antibiotik levofloksasin.
Quality of Life of Outpatients with Type 2 Diabetes Mellitus at Anutapura Hospital Diana, Khusnul; Azizah, Vina Miftahul; Hardani, Muhammad Fakhrul; Tandah, Muhamad Rinaldhi
Farmasains : Jurnal Farmasi dan Ilmu Kesehatan Vol. 11 No. 1 (2026)
Publisher : Universitas Muhammadiyah Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22219/farmasains.v11i1.44208

Abstract

Type 2 Diabetes Mellitus (T2DM) is a chronic disease that may reduce health-related quality of life (HRQoL) because of long-term treatment complications. This study assessed HRQoL among T2DM outpatients at Anutapura Hospital and examined whether the overall HRQoL profile differed by medication group after adjustment for selected patient characteristics. A hospital-based cross-sectional study was conducted at the Internal Medicine Outpatient Clinic of Anutapura Hospital, Palu, Indonesia, from October to December 2024. Using non-probability sampling, 92 adults with T2DM were enrolled and classified into three medication groups: monotherapy oral antidiabetic drugs (OADs), combined OADs, and insulin. HRQoL was measured using the Diabetes Quality of Life Clinical Trial Questionnaire-Revised (DQLCTQ-R), which includes eight domains scored on a 0–100 scale, with higher scores indicating better HRQoL. Internal consistency was acceptable (Cronbach’s alpha = 0.82). Because several domains did not meet normality assumptions, the overall HRQoL profile was analyzed using PERMANOVA. Most respondents were female, aged 41–60 years, and had diabetes duration of less than 5 years. Across medication groups, Physical Function showed the highest scores, whereas Treatment Satisfaction tended to be the lowest. In the adjusted PERMANOVA model, medication group was not significantly associated with the overall HRQoL profile (F = 0.81, p = 0.521, R² = 0.014). In contrast, age (p = 0.016), occupation (p = 0.008), and duration of illness (p = 0.001) were significantly associated with the combined HRQoL profile. These findings suggest that HRQoL differences were more strongly related to patient characteristics than to medication group alone.
Co-Authors Abdul Rahman Razak Adisaputra, Arya Dibyo Afriani Kusumawati Agustinus Widodo Almira Azahriantika Alwiyah Mukaddas Alwiyah Mukaddas amelia rumi, amelia Anggraeni Agus Apriyanti Anastasia Arizah Maulidyah Arya Dibyo Adisaputra Arya Dibyo Adisaputra Ashrawini Omar Aulia, Raiza Aviva Kumala Azizah, Vina Miftahul Balqis, Ratu Basuki, Muhamad Chindy Bestari Rataba Christin Agnes Mega Diwayani Deviani Widnesari Dewi Angriani Dibyo, Arya Ekasandra, Nur Fadhilah Zainal, Setiawati Faradilla, Nadila Fatimah Azzahrah Firdawat Amir Parumpu Firdawati Amir Parumpu Gaby Nathania Angela Mangoting Handoko Putro Hardani, Muhammad Fakhrul Hidayat, Chairunisah Hidayatullah Hidayatullah Ihwam Ihwan Ihwan Ihwan Ingenida Hadning Jamaluddin Katriani, Yan Yan Khusnul Diana Kristiono, Oviani Mallisa, Twulyenna Muhammad Heyqal Wirakarsa Muzna Muzna Nadila Faradilla Ni Luh Yeni Safitri Nina Nurlin Nur Ikhlas Nurhafifah Wulandari Kassa Nurlina Ibrahim Nurul Ambianti Putri, Meliani Putri, Yenita Kartika Ratu Balqis Rhaudatul Janna, Rischa Ririen Hardani Ririen Hardani Sarlina Sarlina Setiawati Fadhilah Zainal Setiawati Fadillah Shella Monica Siti Atika Sri Ayu Noviyanti Syarif Permana Salingkat Syariful Anam Tri Novrianti Djanggola Wirda Suci Ramdhani, Wirda Suci Yuliet Yuliet Yusriadi Yusriadi Zulfiah Zulfiah